Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 12 Radiation Injuries 3 Glioma 3 Glioblastoma 2 Cognitive Dysfunction 2 Astrocytoma 2 Stroke 1 Pituitary Neoplasms 1 Parkinson Disease 1 Oligodendroglioma 1 Neurofibromatosis 1 1 Neoplasm Metastasis 1 Meningioma 1 Medulloblastoma 1 Infratentorial Neoplasms 1 Fatigue 1

Interventions

Temozolomide 74 Radiotherapy 34 Carboplatin 21 Bevacizumab 18 Magnetic Resonance Spectroscopy 17 Irinotecan 16 Carmustine 16 Vincristine 14 Surgical Procedures, Operative 13 Filgrastim 13 Procarbazine 10 Erlotinib Hydrochloride 8 Cyclophosphamide 8 Peripheral Blood Stem Cell Transplantation 7 O(6)-benzylguanine 7 Lomustine 7 Etoposide 7 sargramostim 6 Imatinib Mesylate 6 Flucytosine 6 Cisplatin 6 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 6 temsirolimus 5 Vorinostat 5 Thiotepa 5 Radiotherapy, Intensity-Modulated 5 Radiation 5 Immunohistochemistry 5 Biopsy 5 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Oligodendroglioma × Neuropsychological Tests × CNS × Clear all

NCT02903784 2020-09-02

BNL

University Hospital, Montpellier

Phase NA Completed

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡